674 related articles for article (PubMed ID: 25557336)
1. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
[TBL] [Abstract][Full Text] [Related]
2. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
[TBL] [Abstract][Full Text] [Related]
3. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
Moussata D; Allez M; Cazals-Hatem D; Treton X; Laharie D; Reimund JM; Bertheau P; Bourreille A; Lavergne-Slove A; Brixi H; Branche J; Gornet JM; Stefanescu C; Moreau J; Marteau P; Pelletier AL; Carbonnel F; Seksik P; Simon M; Fléjou JF; Colombel JF; Charlois AL; Roblin X; Nancey S; Bouhnik Y; Berger F; Flourié B;
Gut; 2018 Apr; 67(4):616-624. PubMed ID: 28115492
[TBL] [Abstract][Full Text] [Related]
4. Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases.
Leong RW; Ooi M; Corte C; Yau Y; Kermeen M; Katelaris PH; McDonald C; Ngu M
Gastroenterology; 2017 May; 152(6):1337-1344.e3. PubMed ID: 28126349
[TBL] [Abstract][Full Text] [Related]
5. Carcinogenesis in inflammatory bowel disease.
Herszenyi L; Miheller P; Tulassay Z
Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
[TBL] [Abstract][Full Text] [Related]
6. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
[TBL] [Abstract][Full Text] [Related]
7. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
8. [Surveillance of patients with inflammatory bowel diseases].
Moshkowitz M; Kariv R; Half B; Vilkin A; Levi Z; Niv Y; Dotan I;
Harefuah; 2011 Apr; 150(4):389-91, 417. PubMed ID: 22164923
[TBL] [Abstract][Full Text] [Related]
9. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
10. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
Mpofu C; Watson AJ; Rhodes JM
Cochrane Database Syst Rev; 2004; (2):CD000279. PubMed ID: 15106148
[TBL] [Abstract][Full Text] [Related]
11. Surveillance strategies in inflammatory bowel disease.
Schmidt C; Bielecki C; Felber J; Stallmach A
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):189-201. PubMed ID: 20485256
[TBL] [Abstract][Full Text] [Related]
12. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
Collins PD; Mpofu C; Watson AJ; Rhodes JM
Cochrane Database Syst Rev; 2006 Apr; (2):CD000279. PubMed ID: 16625534
[TBL] [Abstract][Full Text] [Related]
13. Paradigm Shift in the Surveillance and Management of Dysplasia in Inflammatory Bowel Disease (West).
Soetikno R; Kaltenbach T; McQuaid KR; Subramanian V; Kumar R; Barkun AN; Laine L
Dig Endosc; 2016 Apr; 28(3):266-73. PubMed ID: 26866420
[TBL] [Abstract][Full Text] [Related]
14. Colorectal Cancer Screening in Inflammatory Bowel Disease.
Sengupta N; Yee E; Feuerstein JD
Dig Dis Sci; 2016 Apr; 61(4):980-9. PubMed ID: 26646250
[TBL] [Abstract][Full Text] [Related]
15. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
16. Colon cancer in inflammatory bowel disease: recent trends, questions and answers.
Viennot S; Deleporte A; Moussata D; Nancey S; Flourié B; Reimund JM
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S190-201. PubMed ID: 20117342
[TBL] [Abstract][Full Text] [Related]
17. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis.
Broomé U; Löfberg R; Lundqvist K; Veress B
Dis Colon Rectum; 1995 Dec; 38(12):1301-5. PubMed ID: 7497843
[TBL] [Abstract][Full Text] [Related]
18. Image-enhanced endoscopy is critical in the surveillance of patients with colonic IBD.
Subramanian V; Bisschops R
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):393-403. PubMed ID: 24975530
[TBL] [Abstract][Full Text] [Related]
19. An atlas of the nonpolypoid colorectal neoplasms in inflammatory bowel disease.
Soetikno R; Sanduleanu S; Kaltenbach T
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):483-520. PubMed ID: 24975538
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]